7 months ago
ATHA
AnalystsGraig SuvannavejhGraig Suvannavejh's Stock Forecasts
AnalystsGraig Suvannavejh
Analyst Ranking
Bottom 12%
#4333 out of 4870 analysts
Average Return
-1.4%
Win Rate
48%56 out of 117
Risk vs Reward
Poor
Good
Graig Suvannavejh's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Insmed IncINSM | +266.11% | $20.36 | $74.54 | 2023-07-25 - 2024-07-26 | Strong Buy |
Insmed IncINSM | +197.15% | $23.88 | $70.96 | 2023-10-26 - 2024-10-25 | Strong Buy |
Insmed IncINSM | +181.22% | $25.83 | $72.64 | 2024-05-12 - 2025-05-01 | Strong Buy |
Insmed IncINSM | +168.79% | $26.43 | $71.04 | 2023-09-05 - 2024-09-06 | Strong Buy |
Halozyme Therapeutics IncHALO | +136.15% | $18.45 | $43.57 | 2020-01-07 - 2021-01-08 | Strong Buy |
Graig Suvannavejh Analyst Color
Get additional color on Graig Suvannavejh's coverage of popular stocks
a year ago
IMCR
a year ago
ITCI
a year ago
IMCR
a year ago
EYPT
a year ago
AXSM
a year ago
ADVM
2 years ago
BTAI
2 years ago
ITCI
2 years ago
AXSM
2 years ago
AXSM
2 years ago
HRMY
Graig Suvannavejh's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Immunocore Holdings PLCIMCR | 8 | Hold | $33.00 | +9.45% | Maintains | 25 days ago |
Amylyx Pharmaceuticals IncAMLX | 6 | Buy | $7.00 | +36.19% | Upgrades | 25 days ago |
Axsome Therapeutics IncAXSM | 21 | Buy | $216.00 | +92.44% | Maintains | a month ago |
Harmony Biosciences Holdings IncHRMY | 17 | Buy | $44.00 | +47.35% | Maintains | a month ago |
Intra Cellular Therapies IncITCI | 10 | Hold | $132.00 | +0.10% | Downgrades | 2 months ago |
Adaptimmune Therapeutics PLCADAP | 2 | Buy | $1.50 | +445.45% | Maintains | 5 months ago |
Autolus Therapeutics PLCAUTL | 1 | Strong Buy | $7.60 | +462.96% | Upgrades | 5 months ago |
Apellis Pharmaceuticals IncAPLS | 6 | Hold | $38.00 | +89.24% | Maintains | 6 months ago |
Corbus Pharmaceuticals Holdings IncCRBP | 1 | Buy | $74.00 | +884.04% | Reiterates | 7 months ago |
Athira Pharma IncATHA | 3 | Hold | $0.50 | +73.61% | Downgrades | 7 months ago |
Halozyme Therapeutics IncHALO | 4 | Hold | $49.00 | -18.37% | Maintains | 9 months ago |
Ideaya Biosciences IncIDYA | 1 | Buy | $50.00 | +144.26% | Initiates Coverage On | 10 months ago |
Neumora Therapeutics IncNMRA | 1 | Buy | $20.00 | +2,494.03% | Initiates Coverage On | 10 months ago |
Insmed IncINSM | 6 | Strong Buy | $82.00 | +12.89% | Maintains | a year ago |
Immatics NvIMTX | 3 | Strong Buy | $16.00 | +219.36% | Maintains | a year ago |
Eyepoint Pharmaceuticals IncEYPT | 4 | Strong Buy | $30.00 | +320.76% | Maintains | a year ago |
Adverum Biotechnologies IncADVM | 4 | Strong Buy | $22.00 | N/A | Maintains | a year ago |
Immuneering CorpIMRX | 1 | Strong Buy | $8.00 | N/A | Maintains | a year ago |
Corvus Pharmaceuticals IncCRVS | 1 | Hold | $3.50 | N/A | Maintains | a year ago |
Cerevel Therapeutics Holdings IncCERE | 9 | Hold | $45.00 | N/A | Maintains | a year ago |
Terns Pharmaceuticals IncTERN | 5 | Strong Buy | $10.00 | N/A | Maintains | a year ago |
Alector IncALEC | 4 | Strong Buy | $9.00 | N/A | Maintains | a year ago |
Bioxcel Therapeutics IncBTAI | 8 | Hold | $64.00 | N/A | Reiterates | 2 years ago |
Karuna Therapeutics IncKRTX | 3 | Strong Buy | $258.00 | N/A | Maintains | 2 years ago |
Rain Oncology IncRAIN2 | 5 | Hold | $1.00 | N/A | Downgrades | 2 years ago |
Vigil Neuroscience IncVIGL | 1 | Strong Buy | $15.00 | N/A | Initiates Coverage On | 2 years ago |
Rhythm Pharmaceuticals IncRYTM | 3 | Strong Buy | $35.00 | N/A | Maintains | 2 years ago |
Kodiak Sciences IncKOD | 4 | Hold | $8.00 | N/A | Maintains | 2 years ago |
Tg Therapeutics IncTGTX | 2 | Strong Sell | $26.00 | N/A | Downgrades | 3 years ago |
Disc Medicine IncIRON | 2 | Strong Buy | $18.00 | N/A | Maintains | 4 years ago |
Valneva SeVALN | 1 | Strong Buy | $34.00 | N/A | Initiates Coverage On | 4 years ago |
Design Therapeutics IncDSGN | 1 | Hold | $28.00 | N/A | Initiates Coverage On | 4 years ago |
Edgewise Therapeutics IncEWTX | 1 | Hold | $31.00 | N/A | Initiates Coverage On | 4 years ago |
Vor Biopharma IncVOR | 1 | Strong Sell | $19.00 | N/A | Initiates Coverage On | 4 years ago |
Innate Pharma SaIPHA | 1 | Hold | $4.75 | N/A | Initiates Coverage On | 4 years ago |
Arcutis Biotherapeutics IncARQT | 2 | Strong Buy | $36.00 | N/A | Upgrades | 4 years ago |
Cytokinetics IncCYTK | 1 | Hold | $16.00 | N/A | Initiates Coverage On | 5 years ago |
Galapagos NvGLPG | 1 | Strong Sell | N/A | N/A | Downgrades | 5 years ago |
Prelude Therapeutics IncPRLD | 1 | Hold | $37.00 | N/A | Initiates Coverage On | 5 years ago |
Jazz Pharmaceuticals PLCJAZZ | 1 | Strong Sell | $128.00 | N/A | Downgrades | 5 years ago |
Tricida IncTCDAQ | 1 | Hold | $10.00 | N/A | Downgrades | 5 years ago |
Flexion Therapeutics IncFLXN | 1 | Hold | $15.00 | N/A | Initiates Coverage On | 5 years ago |
Momenta Pharmaceuticals IncMNTA | 1 | Hold | $29.00 | N/A | Initiates Coverage On | 5 years ago |
Horizon Therapeutics Public Ltd CoHZNP | 1 | Hold | $35.00 | N/A | Initiates Coverage On | 5 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.